Article
Statistical Considerations for Clinical Trials During COVID-19: Impacts on Permuted Block Randomization and Mitigations
LinkedIn
Document Type
Article
Publication Date
4-28-2020
Disciplines
Abstract
Randomization is the foundation of any randomized controlled trial involving treatment comparisons. The major benefits of randomization in the context of clinical trials are:
- Randomization helps mitigate various experimental biases.
- It promotes comparability of treatment groups with respect to important known and unknown prognostic factors that may be correlated with the primary outcome.
- It is the basis for the validity of standard statistical tests and makes the underlying assumptions of random sampling more plausible.
- It can form the basis for statistical inference through re-randomization tests.
Citation Information
Qing Liu and Karl E. Peace. "Statistical Considerations for Clinical Trials During COVID-19: Impacts on Permuted Block Randomization and Mitigations" LinkedIn (2020) Available at: http://works.bepress.com/karl_peace/373/